Skip to content

Common Stock at other companies

Alkermes logo
AlkermesALKS
$1.84M+1.9%
JAN
Janus Living JAN
2B+900%

Other financials

Income statement

See full
Revenue$317.0M+19.2%
Gross profit$277.0M+24.8%
Operating income$137.0M+108%
Net income$89.0M+89.4%
EPS (diluted)$0.69+81.6%

Balance sheet

See full
Cash & equivalents$175.0M-53.0%
Total debt$509.0M+37.6%
Total equity-$144.0M+49.5%
Total assets$1.2B-12.9%

Cash flow

See full
Operating cash flow-$9.0M-112%
CapEx$20.0M+300%
Free cash flow-$29.0M-141%

Valuation

See full
Market cap$4.53B+213%

Profitability

See full
Gross margin81.3%+1.5pp
Operating margin25.8%+23.3pp
Net margin19.4%+18.9pp
FCF margin-14.9%

Returns & leverage

See full
Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's common stock?
Indivior Pharmaceuticals, Inc. (INDV) reported common stock of $0 in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's common stock changed year-over-year?
Indivior Pharmaceuticals, Inc. 's common stock decreased by 100.0% year-over-year, from $62M to $0.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's common stock?
Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's common stock has grown at a -4.5% compound annual growth rate (CAGR), from $68M to $62M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).